NEWAMSTERDAM PHARMA COMPANY NV share price logo

NEWAMSTERDAM PHARMA COMPANY NV Share Price

NASDAQ: NAMS

Mid Cap

$30.07

+0.05

(+0.18%)

as on

NEWAMSTERDAM PHARMA COMPANY NV Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $28.98
    $30.66
    downward going graph

    3.62%

    Downside

    1.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $14.06
    $42.00
    downward going graph

    53.24%

    Downside

    39.67%

    Upside

    downward going graph

NEWAMSTERDAM PHARMA COMPANY NV share price movements today

Previous Close
$30.01
Open
$29.71
Volume
773.4K
Day's Low - High
$28.98 - $30.66
52 Week Low - High
$14.06 - $42.00

NEWAMSTERDAM PHARMA COMPANY NV Historical Returns

1 Month Return
-14.28 %
3 Month Return
-15.82 %
1 Year Return
+ 28.19 %
3 Year Return
+ 119.21 %
5 Year Return
0 %

NEWAMSTERDAM PHARMA COMPANY NV Stock Fundamentals & Key Indicators

Check NEWAMSTERDAM PHARMA COMPANY NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.3B

EPS (TTM)

-1.6862

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-225.5M

Revenue (TTM)

22.5M

Profit Margin

0.00%

Return On Equity TTM

-28.29%

NEWAMSTERDAM PHARMA COMPANY NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NEWAMSTERDAM PHARMA COMPANY NV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NEWAMSTERDAM PHARMA COMPANY NV image
NEWAMSTERDAM PHARMA COMPANY NV
BUY$3.3BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for NEWAMSTERDAM PHARMA COMPANY NV Stock including INR - Dollar returns

The NEWAMSTERDAM PHARMA COMPANY NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

NEWAMSTERDAM PHARMA COMPANY NV investment value today

Current value as on today

₹1,37,990

Returns

₹37,990

(+37.99%)

Returns from NEWAMSTERDAM PHARMA COMPANY NV Stock

₹28,449 (+28.45%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on NEWAMSTERDAM PHARMA COMPANY NV Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for NEWAMSTERDAM PHARMA COMPANY NV. Average target price of $48.86

NEWAMSTERDAM PHARMA COMPANY NV Share Price Target

Get share price movements and forecasts by analysts on NEWAMSTERDAM PHARMA COMPANY NV.

What analysts predicted

38.46%UPSIDE

Target Price

$48.86

Current Price

$30.07

Analyzed by

14 Analysts

Target

$48.86

NEWAMSTERDAM PHARMA COMPANY NV target price $48.86, a slight upside of 38.46% compared to current price of $30.07. According to 14 analysts rating.

NEWAMSTERDAM PHARMA COMPANY NV Stock’s Investor Sentiment and Interest

Search interest for NEWAMSTERDAM PHARMA COMPANY NV Stock has increased by 75% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:75% versus previous 30 day period

NEWAMSTERDAM PHARMA COMPANY NV Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
3
0
1
2
32
12
2
19
0
0
Gross Profit
3
0
1
2
32
12
2
19
0
0
Operating Income
-49
-51
-55
-52
-25
-43
-68
-35
-55
-65
EBITDA
-49
-50
-55
-51
-23
-111
-68
-35
-71
-65
Interest Expense
0
1
0
0
1
3
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-47
-49
-93
-39
-16
-92
-39
-17
-72
-74
Income Tax Expense
0
0
-3
-12
0
-
-
-
-
-
Net Income
-50
-53
-101
-41
-18
-92
-39
-17
-72
-74
Net Profit Margin
-1602.62%
-6163.76%
-6692.86%
-1711.58%
-57.18%
-721.71%
-1327.30%
-90.70%
-20691.09%
-234134.38%

NEWAMSTERDAM PHARMA COMPANY NV Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
108
15
45
22
Gross Profit
-
0
108
15
45
22
Operating Income
-6
-34
-3
-182
-176
-225
EBITDA
-6
-41
-22
-176
-241
-242
Interest Expense
0
0
0
6
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-7
-41
-22
-176
-241
-203
Income Tax Expense
0
0
70
0
0
-
Net Income
-8
-47
-23
-193
-241
-203
Net Profit Margin
0.00%
0.00%
-22.04%
-1255.76%
-530.25%
-905.74%

NEWAMSTERDAM PHARMA COMPANY NV Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-49
-93
-39
-16
-92
-39
-17
39
-74
Operating Cash Flow
-33
-54
-53
-12
-37
-36
-37
-32
-40
Investing Cash Flow
0
0
0
0
-62
2
-159
2
-21
Financing Cash Flow
0
198
4
0
456
6
3
5
13
Change in Cash
-27
140
-50
-7
349
-23
-184
-24
-48

NEWAMSTERDAM PHARMA COMPANY NV Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-41
-22
-176
-241
-203
Operating Cash Flow
-29
10
-141
-158
-147
Investing Cash Flow
0
0
0
-62
-174
Financing Cash Flow
84
391
8
659
29
Change in Cash
50
407
-127
431
-280

Global Institutional Holdings in NEWAMSTERDAM PHARMA COMPANY NV

Funds
Holdings
Capital Research & Mgmt Co - Division 3
1.79%
FCPM III SERVICES BV
8.01%
Wellington Management Company LLP
4.38%
Maverick Capital Ltd
1.31%
Polar Capital Holdings PLC
2.41%
See all

Insights on NEWAMSTERDAM PHARMA COMPANY NV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NAMS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, NAMS stock has moved up by 119.2%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NAMS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 19.14M → 32.0K (in $), with an average decrease of 94.5% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -17.36M → -74.92M (in $), with an average decrease of 159.4% per quarter

About NEWAMSTERDAM PHARMA COMPANY NV

NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.
OrganisationNEWAMSTERDAM PHARMA COMPANY NV
HeadquartersGooimeer 2-35, Naarden, Netherlands, 1411 DC
CEODr. Michael Harvey Davidson FACC, Facp., M.D.
E-voting on sharesClick here to vote

Key Management of NEWAMSTERDAM PHARMA COMPANY NV

Name

Title

Mr. Matthew Philippe

Executive VP &Head of Investor Relations

Ms. Maryellen McQuade

Chief People Officer

Ms. Juliette Audet M.B.A., M.Sc.

Chief Strategy & Business Officer

Dr. Marc Ditmarsch M.D.

Chief Development Officer

Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.

Founder, Chief Scientific Officer, Member of Executive Board & Director

Mr. Mayur Amrat Somaiya

Chief Financial Officer

Mr. Douglas F. Kling

Chief Operating Officer

Ms. Louise Kooij

Chief Accounting Officer

Dr. Michael Harvey Davidson FACC, Facp., M.D.

CEO, President & Executive Director

Mr. Bob Rambo

Executive Vice President of Marketing

FAQs

What is NEWAMSTERDAM PHARMA COMPANY NV share price today?

NEWAMSTERDAM PHARMA COMPANY NV share price today is $30.07 as on at the close of the market. NEWAMSTERDAM PHARMA COMPANY NV share today touched a day high of $30.66 and a low of $28.98.

What is the 52 week high and 52 week low for NEWAMSTERDAM PHARMA COMPANY NV share?

NEWAMSTERDAM PHARMA COMPANY NV share touched a 52 week high of $42 on and a 52 week low of $14.06 on . NEWAMSTERDAM PHARMA COMPANY NV stock price today i.e. is closed at $30.07,which is 28.40% down from its 52 week high and 113.87% up from its 52 week low.

What is NEWAMSTERDAM PHARMA COMPANY NV's market capitalisation today?

NEWAMSTERDAM PHARMA COMPANY NV market capitalisation is $0.00T as on .

How to invest in NEWAMSTERDAM PHARMA COMPANY NV Stock (NAMS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NEWAMSTERDAM PHARMA COMPANY NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NEWAMSTERDAM PHARMA COMPANY NV Shares that will get you 0.0499 shares as per NEWAMSTERDAM PHARMA COMPANY NV share price of $30.07 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy NEWAMSTERDAM PHARMA COMPANY NV Stock (NAMS) from India?

Indian investors can start investing in NEWAMSTERDAM PHARMA COMPANY NV (NAMS) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in NEWAMSTERDAM PHARMA COMPANY NV stock (as per the Rupee-Dollar exchange rate as on ). Based on NEWAMSTERDAM PHARMA COMPANY NV share’s latest price of $30.07 as on March 25, 2026 at 1:29 am IST, you will get 0.3326 shares of NEWAMSTERDAM PHARMA COMPANY NV. Learn more about fractional shares .